Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 4Phase 1 3Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Carcinoma, Ductal, Breast 2Breast Neoplasms 2Sarcoma 1Ovarian Neoplasms 1Desmoplastic Small Round Cell Tumor 1Carcinoma, Lobular 1

Interventions

pembrolizumab 3Oncolytic Virotherapy 3Magnetic Resonance Spectroscopy 3Specimen Handling 2Radiotherapy 2Nivolumab 2Irinotecan 2Doxorubicin 2Cyclophosphamide 2trastuzumab biosimilar HLX02 1sodium thiosulfate 1pertuzumab 1perflutren 1palbociclib 1olaparib 1niraparib 1montelukast 1eribulin 1entrectinib 1cobimetinib 1camrelizumab 1atezolizumab 1apatinib 1alovudine 1alectinib 1X-Rays 1Vinorelbine 1Vincristine 1Vemurafenib 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Sarcoma × Chemotherapy, Adjuvant × Clear all
NCT00662233 2018-10-09

Combination Chemotherapy in Treating Patients With Sarcoma

Mayo Clinic

Phase EARLY_PHASE1 Completed
28 enrolled
GynecologicSarcoma

Ovarian Neoplasms, Sarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡